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Schema therapy for Dissociative Identity Disorder (DID): rationale and study
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aDepartment of Experimental Psychotherapy and Psychopathology, University of Groningen, Groningen, the Netherlands; bDepartment
of Clinical Psychological Science, Maastricht University, Maastricht, the Netherlands; cDepartment of Clinical Psychology, University of
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ABSTRACT
Background: A category of disorders frequently associated with a history of trauma are
the dissociative disorders, of which Dissociative Identity Disorder (DID) is the most severe
and chronic form. DID is associated with high levels of impairment, treatment utilization,
and treatment costs, yet systematic research into treatment effects is scarce. Practice-
based clinical guidelines advise a phase-based approach which is lengthy and has rather
high reported dropout rates. Therefore, in the current proposal the efficacy of an
alternative treatment for DID (i.e. schema therapy) is tested.
Objective: The aim of this study is to critically test the effectiveness of schema therapy for
DID patients, for whom at present no evidence-based treatment is available.
Method: In light of the low prevalence of DID, and the proposed treatment length of three
years, a case series experimental approach is used (non-concurrent multiple baseline design).
Ten outpatients are included, who are diagnosed with DID by an independent rater using the
Structured Clinical Interview for DSM-IV Dissociative Disorders (SCID-D-R), which is double-
checked by another independent expert. Primary outcomes are a (bi)weekly assessed state
measure of dissociative symptoms, a pre-, post- and follow-up measure of the presence of the
DID diagnosis, and drop-out rate. Secondary outcomes include various measures of trait
dissociative symptoms, comorbid symptomatology, and global symptomatic distress.
Trial registration: Netherlands Trial Register (NTR): NTR4496
Terapia de esquema para el trastorno de identidad disociativo (DID):
justificación y protocolo de estudio
Antecedentes: Una categoría de trastornos frecuentemente asociados con un historial de
trauma son los trastornos disociativos, de los cuales el trastorno de identidad disociativo
(DID, por sus siglas en inglés) es la forma más grave y crónica. El DID se asocia con altos
niveles de deterioro, utilización y costos de tratamiento, aunque la investigación sistemática
sobre los efectos de tratamiento es escasa. Las guías clínicas basadas en la práctica
aconsejan un enfoque basado en fases que es largo y tiene tasas reportadas de deserción
más bien altas. Por lo tanto, en la propuesta actual, se prueba la eficacia de un tratamiento
alternativo para DID (es decir, terapia de esquema).
Objetivo: El objetivo de este estudio es probar críticamente la efectividad de la terapia de
esquema para pacientes con DID, para quienes en la actualidad no hay disponible un
tratamiento basado en la evidencia.
Método: En vista de la baja prevalencia de DID y la duración del tratamiento de tres años
propuesto, se utiliza un enfoque experimental de series de casos (diseño de línea base
múltiple no concurrente). Se incluyen diez pacientes ambulatorios, que son diagnosticados
con DID por un evaluador independiente usando el SCID-D-R, que es verificado por otro
experto independiente. Los resultados primarios son una medida (bi)semanal de estado de
síntomas disociativos, una medida previa, posterior y de seguimiento de la presencia del
diagnóstico de DID, y tasa de deserción. Los resultados secundarios incluyen diversas
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• At present, no evidence-
based treatment is available
for DID patients.
• Practice-based clinical
guidelines advise a phase-
based approach.
• Drawback of this phase-
based approach is its
substantial average length
and dropout rates.
• In the current study, the
efficacy of an alternative
approach to treatment for
DID (i.e. schema therapy) is
tested using a case series
design.
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Clinical and epidemiological research has indicated a
significant association between trauma exposure and a
variety of psychological disorders (e.g. Fierman et al.,
1993; Leskin & Sheikh, 2002). One category of disor-
ders frequently associated with a history of trauma are
the dissociative disorders, of which Dissociative
Identity Disorder (DID) is the most severe and chronic
form (Dalenberg et al., 2012; see Giesbrecht, Lynn,
Lilienfeld, & Merckelbach, 2008, for a critical evalua-
tion of the association between trauma and DID).
Although dissociative symptoms can be found in
many mental disorders, highest levels of dissociative
experiences were found in DID (Lyssenko et al., 2018).
The main diagnostic criterion for DID is a disruption
of identity characterized by two or more distinct per-
sonality states. The disruption in identity involves
marked discontinuity in sense of self and sense of
agency, and is accompanied by alterations in affect,
behaviour, consciousness, memory, perception, cogni-
tion, and/or sensory-motor functioning. In addition,
the patient experiences recurrent gaps in the recall of
everyday events, important personal information, and/
or traumatic events (DSM-5; American Psychiatric
Association, 2013). The DSM-5 estimates the
12-month prevalence of DID as 1.5% of the population
of American adults (American Psychiatric Association,
2013). The prevalence in psychiatric settings has been
estimated to be around 5% (range 0.4–14%; Şar, 2011).
However, these estimations are generally not based on
strict assessment procedures and therefore are prob-
ably overestimating the real prevalence. Patients suf-
fering from DID show high levels of impairment, high
treatment utilization, and high treatment costs (Ross &
Dua, 1993). Of all dissociative disorders, DID patients
have the highest mean impairment scores on measures
of psychosocial, occupational, and interpersonal func-
tioning (Johnson, Cohen, Kasen, & Brook, 2006).
These impairment scores are over 50% higher than
those of patients with other syndromal or personality
related psychiatric disorders, and results remained sig-
nificant after controlling for age, gender, and comor-
bid disorders (Johnson et al., 2006; Mueller-Pfeiffer et
al., 2012). Dissociative disorder pathology is also
strongly related to self-harm and multiple suicide
attempts (Foote, Smolin, Neft, & Lipschitz, 2008).
DID patients specifically are at high risk for early
mortality, and are among the most expensive patients
in the mental health care system (Galbraith &
Neubauer, 2000).
1.1. Treatment for Dissociative Identity Disorder
and evidence regarding its effectiveness
No formal, evidence-based treatment guidelines are
available for DID (e.g. National Institute for health
and Care Excellence [NICE] guidelines). The most
commonly provided treatment approach for DID is
individual psychodynamic psychotherapy (Brand,
Classen, McNary, & Zaveri, 2009; Putnam &
Loewenstein, 1993). According to practice-based
guidelines initiated by the International Society for
the Study of Trauma and Dissociation (ISSTD, 2011),
DID treatment preferably is delivered in sequenced
stages or phases. Generally, this treatment encom-
passes three phases. In the first phase safety and
symptom stabilization is established, in the second
phase traumatic memories are confronted and pro-
cessed, and in the third phase identity integration and
rehabilitation is addressed (International Society for
the Study of Trauma and Dissociation, 2011).
Following a basic tenet of compartmentalized identi-
ties, the main aim of this treatment is to bring about
an increased degree of co-consciousness, communi-
cation, and integrated functioning among the differ-
ent parts, facilitating the processing of
compartmentalized traumatic memories, and the
integration of separate identities in the second and
third stage of therapy (International Society for the
Study of Trauma and Dissociation, 2011). It is
thought that a lack of concentration on stabilization,
and/or a premature focus on detailed exposure to and
processing of traumatic memories, will result in over-
whelming emotions, exacerbation of symptoms, and
decompensation of the patient, accompanied by
increased deterioration in day-to-day functioning
(Brand, Loewenstein, & Spiegel, 2014). The second,
trauma-focused, phase of therapy is considered too
destabilizing for chronically low-functioning patients,
including those with severe attachment problems,
minimal ego strength and coping capacity, ongoing
enmeshment with perpetrators, severe personality
pathology, significant medical problems, and ongoing
substance abuse and dependency (International
Society for the Study of Trauma and Dissociation,
2011). Hence, phase two is only started when there
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are relatively few life stressors, and there is enough
ego strength, commitment to treatment, social sup-
port, economic resources, and other factors that help
patients to undertake a demanding, change-oriented
treatment. Consequently, patients may stay in phase
one for long periods of time, sometimes even for the
entire course of treatment, which may last 10 years or
longer.
Research on the effectiveness and efficacy of DID
treatments is still in its infancy, partly because
patients with these disorders are usually excluded
from treatment studies (e.g. due to their complexity,
poly-symptomatology, and the long treatment
length they are supposed to need), even when these
studies involve treatment of patients who faced
chronic childhood abuse (e.g. Van der Kolk &
Courtois, 2005). In a review of eight treatment out-
come studies of dissociative disorders (most
included patients had DID or dissociative disorder
not otherwise specified; DDNOS), all nonrando-
mized, Brand, Classen, McNary, & Zaveri (2009)
concluded that treatment was associated with a
reduction of dissociative symptoms from pre- to
post-treatment (mean effect size Hedges g = .70),
and a range of associated symptoms (including
symptoms of anxiety, borderline personality disor-
der (BPD), depression, substance use, and general
distress; mean overall outcome effect size g = .72 at
discharge, and .66 at follow-up ranging from
three months to two years). In addition, Brand and
colleagues (Brand, Classen, Lanius, et al., 2009, 2013;
Myrick, Webermann, Loewenstein, Lanius, Putnam,
& Brand, 2017) performed an observational prospec-
tive naturalistic survey study following DID and
DDNOS outpatients and their therapists. Each par-
ticipating therapist self-selected a patient from his or
her caseload, who was followed for a period of
30 months. Patients had been in treatment with the
current therapist for an average of five years, and
had been formally diagnosed with DID or DDNOS
for an average of seven years. Positive treatment
results were reported: in addition to a decrease on
a range of symptoms (e.g. dissociative symptoms,
posttraumatic stress disorder symptoms, general dis-
tress), both patients and therapists reported an
improvement in social functioning for patients,
and a decrease in, among others, drug use, self-
injurious behaviour, and number of hospitalizations.
It was also suggested that treatment was associated
with reduced inpatient and outpatient costs over
time (Myrick, Webermann, Langeland, Putnam, &
Brand, 2017).
Jepsen, Langeland, Sexton, and Heird (2014) inves-
tigated symptomatic change in patients suffering from
a history of childhood sexual abuse with versus with-
out a complex dissociative disorder (CDD, with com-
plex referring to DID and DDNOS-1, see Dell, 2009)
attending a three-months inpatient phase-one treat-
ment (i.e. stabilization). Results indicated that, whereas
patients with CDD had higher symptom levels pre-
treatment, both patient groups showed parallel
improvement on dimensional symptom measures for
posttraumatic stress symptoms, general psychiatric
symptoms, interpersonal problems, depressive symp-
tomatology, and dissociative symptoms from admis-
sion to 12-months follow-up (mean effect size Cohen’s
d = 0.43 for the CDD group and 0.68 for the non-
CDD group).
These studies provide preliminary evidence of
treatment effectiveness on a range of symptoms
associated with DID. Yet, the number of studies
has been very small. Moreover, previous studies
suffer from major methodological shortcomings,
limiting both internal and external validity (i.e. gen-
eralizability). Most of the studies did not report
whether changes following treatment constituted
clinically meaningful changes. Details on treatment
programmes were missing, as all studies included
non-manualized interventions, rendering replication
difficult, if not impossible. Furthermore, most of the
studies relied on a single therapist and a single
treatment site. Yet, most important, studies lacked
an adequately randomized controlled design. There
were no comparison groups (i.e. a patient group
without treatment or with an alternative treatment)
or comparison conditions, (e.g. the inclusion of a
baseline measurement phase; as an exception of the
latter see the case study by Kellett, 2005). As a
consequence, it cannot be determined if, and if so,
how much patients would have improved without
treatment. Hence, it is impossible to know whether
change occurred due to treatment or some other
variable (e.g. the passage of time, regression to the
mean, or placebo effects). It is even possible that no
treatment would result in better results than the
treatment provided. Another limitation is that, for
most studies, diagnostic status was not based on
structured interviews, leaving it undetermined
whether true cases of DID were included. Also,
several studies suffered from problematic high
drop-out rates (i.e. 60% in a study by Ellason &
Ross, 1997; 68% in Gantt & Tinnin, 2007), whilst
in other studies drop-out was not reported (Ross &
Ellason, 2001), rendering the external generalization
of results hazardous. Based on the results of these
uncontrolled studies, changes following treatment
cannot be causally attributed to the treatment, as it
is also possible that improvement would have
occurred without treatment (Brand, 2012).
Besides the lack of controlled studies to test the
effectiveness and efficacy of the phase-based approach
for DID, there is room for improvement in the treat-
ment of DID. As mentioned before, drop-out is rela-
tively high and the treatment is intensive and lengthy.
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The minimum frequency of sessions for most DID
patients is once a week, with many experts advising
two or three sessions a week. Statistics on the mean
length of treatment are scarce. Groenendijk and van
der Hart (1995) mentioned a mean length of six years
of treatment, based on therapist reports, in a combined
sample of DID and DDNOS patients. In the aforemen-
tioned study by Brand and colleagues, patients in the
last phase of treatment were seen by the current thera-
pist for over eight years (Brand, Classen, Lanius, et al.,
2009). Notably, during these years many patients stay
in phase-one
(i.e. with a continuous focus on stabilization, crisis
management, and symptom reduction) and, hence,
will not reach the second phase of therapy. Only a
minority of DID patients reach phase three (22% in
Ellason & Ross, 1997; 7% in Brand, Classen, Lanius, et
al., 2009).
Although we consider stabilization techniques
(i.e. throughout treatment) important for these
patients, we consider delaying or restricting access
to effective (phase two) trauma-focused treatments
may be potentially harmful to patients (for a com-
parable argumentation in the context of PTSD see
Neuner, 2008).
Whereas treatment outcome for DID or DDNOS
seem to be associated with improvement across a
wide range of outcomes, this is not always the case.
In some studies, no pre- to post-treatment change
in dissociation scores were found (e.g. Jepsen et al.,
2014; Ross & Ellason, 2001) and amnesia scores
even worsened (Choe & Kluft, 1995). In the studies
that report positive effects, most patients do not
completely recover from their chronic struggles
with severe dissociation, PTSD, depression, and
general distress. For example, in the study by
Gantt and Tinnin (2007), 68% of the patients diag-
nosed with DID or DDNOS did not ’recover’. Thus,
whereas treatment is associated with a decrease of a
wide range of symptoms, patients typically do not
recover.
To summarize, the phase-based approach of DID
seems related to reduced levels of dissociative and
comorbid symptomatology. However, the level of
evidence for these findings is low, as previous studies
suffer from serious methodological weaknesses. We
do not know how these improvements compare to
what is observed during the passage of time.
1.2. Rational for an alternative treatment:
schema therapy
Whereas DID patients may subjectively perceive their
different identities as compartmentalized, empirical
evidence from the experimental psychopathology
field contradicts the view of identities with separate
memory store divided by amnesic barriers. A series of
studies in different labs assessed the transfer of infor-
mation between identities in DID. Both tests of impli-
cit and explicit memory were included, and neutral,
emotional, and autobiographical information. The
data across studies were consistent in that, subjectively,
DID patients reported amnesia among identities, but
objectively, no evidence was found for inter-identity
amnesia (for an overview, see Dorahy & Huntjens,
2007; Huntjens, Verschuere, & McNally, 2012). In
sum, these studies do not support the view of com-
partmentalized personalities but show intact memory
pathways. Whereas the DID patient may – on a meta-
cognitive level – not acknowledge all memories as
‘personal’ memory in each identity state, this is not
to say that memory functioning in DID is compart-
mentalized or impaired in other ways (Huntjens,
Postma, Peters, Woertman, & van der Hart, 2003).
Moreover, it is important to note that shifts among
feelings, emotions, and behaviours, as often seen in
DID, also appear in other disorders related to severe,
early, and prolonged childhood abuse, including BPD,
other personality disorders, and PTSD (Arntz,
Klokman, & Sieswerda, 2005; Johnston, Dorahy,
Courtney, Bayles, & O’Kane, 2009). Note that DID
and BPD are highly comorbid conditions (Gleaves,
May, & Cardeña, 2001).
An evidence-based treatment for patients with
personality disorders is schema therapy (for reviews
see Jacob & Arntz, 2013; Masley, Gillanders,
Simpson, & Taylor, 2012; Sempértegui, Karreman,
Arntz, & Bekker, 2013). Schema therapy is an inte-
grative therapy lasting 1–3 years, blending traditional
cognitive behavioural treatment with experiential and
interpersonal elements (Young, 1990; Young &
Gluhoski, 1996; Young, Klosko, & Weishaar, 2003),
and using the therapeutic relationship as an impor-
tant vehicle to bring about corrective emotional
experiences (see Nordahl & Nysæter, 2005; Young et
al., 2003). Schema therapy seems a viable option for
the treatment of DID given its emphasis on the con-
sequences of early childhood neglect and abuse, and
the explanation within the therapeutic model of the
patient’s experience of drastic shifts between states.
Unlike the ISSTD guidelines, that tend to reify the
idea of severely dissociated identities with amnestic
barriers, in the e model these states are not consid-
ered as ‘compartmentalized’ identity states. Schema
therapy aims to normalize for the patient the differ-
ent ‘identities’ by reframing them as modes (or as
parts of modes), which are common in all humans,
though different in their degree of intensity, and
amnestic barriers are not assumed. The various iden-
tities of a patient with DID are regarded as extreme
expressions of dysfunctional modes, differing from
the modes of patients with PDs in how the patient
experiences the mode, thus in degree of experienced
dissociation from the other modes (Johnston et al.,
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2009; Lobbestael, van Vreeswijk, & Arntz, 2007;
Young et al., 2003).
Treatment effect studies into schema therapy
yielded robust results. In comparison to other treat-
ment conditions, in schema therapy relatively low
drop-out rates were found for BPD (less than 10% in
the first year of treatment) (Farrell, Shaw, &
Webber, 2009; Giesen-Bloo et al., 2006; Nadort et
al., 2009) and for other personality disorders
(Bamelis, Evers, Spinhoven, & Arntz, 2014). An
explanation might be that patients in the schema
therapy condition highly valued the therapeutic rela-
tionship (see for empirical evidence: Spinhoven,
Giesen-Bloo, van Dyck, Kooiman, & Arntz, 2007).
Next, symptoms were found to reduce significantly.
After 2–3 years of treatment with schema therapy,
45–90% of the patients recovered, i.e. did not meet
criteria of a formal diagnosis anymore (Bamelis et
al., 2014; Farrell et al., 2009; Giesen-Bloo et al.,
2006). Giesen-Bloo and colleagues (2006) also
looked into the effectiveness of schema therapy on
dissociative symptoms, using the subscale ‘Paranoid
and Dissociative Ideation’ of the Borderline
Personality Disorder Severity Index (Arntz et al.,
2003). Schema therapy resulted in significant lower
scores on the scale, with the effects already apparent
after one year of treatment. However, as this sub-
scale is a combination score, it was unclear whether
this effect is evident in dissociative symptoms, para-
noid ideation symptoms, or both. Moreover, DID
patients were excluded from this study, so it remains
unknown whether schema therapy (ST) is effective
in this specific group of patients as well.
1.3. The present study
Farrell and Shaw adapted their ST treatment, origin-
ally developed and tested in BPD (Farrell & Shaw,
2012; Farrell et al., 2009; Reiss, Lieb, Arntz, Shaw, &
Farrell, 2014), to meet the needs of DID patients.
They piloted this adaptation in six inpatients suffer-
ing from DID. The positive clinical observations of
this effort led to the development of a detailed stan-
dardized protocol of schema therapy for DID (Shaw,
Rijkeboer, Huntjens, Arntz, & Farrell, 2014). Central
in this treatment is the acknowledgment and valida-
tion of both the patient’s subjective experience of
alternating senses of self, sense of agency, and of
differential identity functioning, and the subjective
experience of (inter-identity) amnesia, whilst at the
same time compartmentalization of identities is not
assumed. Early in treatment patients are educated on
the various modes, the function of shown behaviours
when in certain modes, and the basic emotional
needs that drive these modes. Gradually identities
are grouped by their function, constantly focusing
on the underlying needs. The adaptations to the
original schema therapy protocol in order to treat
DID patients include the following. First, there is a
much slower pace overall. Patients have to adjust to
this model that is sometimes very different from what
they have learned about their pathology so far. Also,
patients are intensely vulnerable, with frequent dis-
sociative reactions and extreme avoidant behaviour.
In order to keep the patient in control, the therapist
constantly needs to slow down the process, much
more than in the treatment of BPD. Next, several
techniques are added to help patients stay focused
in the present reality. Also, metaphors and stories
are provided to help patients understand and validate
their needs, feelings, thoughts, and behaviours, thus
normalizing these. Moreover, aggressive, critical
modes are dealt with more patiently than in BPD
treatment. Close attention is paid to their function
and their needs are validated, followed by education
on how messages of abusive family members or
acquaintances get internalized. Whereas the actual
aggressive actions are stopped during the session,
patients in this mode are gradually invited to use
their strength to get rid of this ongoing victimization.
Furthermore, the technique imagery rescripting is cut
into small steps, in order to be able to start with the
processing of traumatic experiences relatively early in
therapy. Also patients are helped to gradually over-
come cognitive avoidance, a central characteristic of
DID (see Huntjens, Wessel, Hermans, & van Minnen,
2014), by the consistent use of experiential techni-
ques, which form an important ingredient of schema
therapy. Therapists need to be aware not to give in to
the inclination to rescue the patient; next to a warm
and empathic attitude they need to set limits and be
firm in helping the patient to step-by-step break
through the avoidance. Finally, there is a strong
emphasis on relaxing activities and other positive
experiences, and the progress (successes) in therapy
is regularly evaluated with the patient, much more so
than in the treatment of BPD.
The aim of the present study is to critically test
this treatment protocol in DID patients. Whereas
RCTs are generally considered the ‘gold standard’
for testing therapy effectiveness, there are limita-
tions with respect to feasibility, costs, and external
validity (e.g. Hawkins, Sanson-Fisher, Shakeshaft,
D’Este, & Green, 2007). Therefore, and given the
lengthy treatment of these patients, as a powerful
alternative we use a multiple baseline case series
design (Onghena, 2005). Multiple baseline case
series fit with daily practice more closely than
RCTs (Kazdin, 2011). There is also an ethical
advantage: in comparison to RCTs, less patients
have to be included. More specifically, we utilize a
multicentre, non-concurrent multiple baseline
design. Different baseline lengths are determined
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before the start of the study. When a patient is
included, he/she is randomly assigned to one of
the predetermined baseline lengths. The baseline
condition consists of a waitlist control period.
Patients complete weekly assessments in this per-
iod, but do not receive any psychotherapy.
Advantages of this approach are (a) patients
serve as their own controls and (b) variation in
baseline lengths offers the possibility to differenti-
ate between time effects and experimental effects
of the treatment. We also included an education
condition. By adding this condition (i.e. develop-
ing an idiosyncratic case-conceptualization and
explaining the therapy model), it is possible to
control for the effect of attention, thus increasing
the power of the design (see Arntz, Sofi, & van
Breukelen, 2013). No treatment effects are
expected in this phase. Baseline observations are
carried out and, after an education phase, the
treatment is implemented. Observations are con-
tinued throughout the intervention phase. Every
two weeks, dissociative and posttraumatic symp-
toms are measured. Additionally, various pre-,
post-, six-, and 12-month follow-up measures are
included, encompassing an assessment of the pre-
sence of DID, trait dissociative symptoms, comor-




Ten DID outpatients are recruited in several commu-
nity mental health institutes in the Netherlands. The
inclusion criteria are (1) a main diagnosis of DID, (2)
age between 18 and 60 years, and (3) Dutch literacy.
Exclusion criteria are (1) mental retardation (IQ < 80),
(2) a current drug/alcohol dependency, (3) acute sui-
cide risk, (4) present florid psychotic episodes, (5)
previous schema therapy, and (6) completed trauma-
focused treatment. Other comorbid syndrome or per-
sonality disorders are allowed, as is medication use
(this is monitored throughout the treatment) and
ongoing sexual/physical abuse.
2.2. Intervention
Treatment consists of two individual sessions a week
for 160 sessions, followed by 40 individual sessions
once a week, with each session lasting 50 minutes.
After treatment, patients receive six monthly booster
sessions. The treatment is theoretically consistent
with the model described in Young et al. (2003),
and adapted for the specific treatment needs of DID
patients. For this purpose, a treatment protocol was
developed that identifies the goals of treatment,
describes the various techniques, and contains a
workbook of patient materials (Shaw et al., 2014).
Patients are not allowed to receive concurrent addi-
tional psychological treatment.
2.3. Treatment integrity check
All participating therapists are well trained and
licensed cognitive behavioural therapy (CBT) and
ST therapists. To optimize treatment integrity, thera-
pists received a two-day training in which the treat-
ment protocol for DID was critically discussed and
practiced. Furthermore, during the study the thera-
pists are supervised monthly by the third author in
subgroups of maximal five therapists via video con-
ferencing. Also, peer supervision sessions are held
every month via video conferencing in the same sub-
groups. Finally, all therapy sessions are recorded on
audiotape. At random, tapes will be selected and
rated for treatment integrity by independent raters
using a treatment adherence scale.
2.4. Study design and procedure
Patients are recruited from community mental health
care centres and receive written study information.
After informed consent, diagnosis is independently ver-
ified by a trained clinician by taking the SCID-D-R.
Hereafter, a second independent expert on DID diag-
nostic assessment provides a second opinion in each
case, based on the interview recordings of the SCID-D-
R, and a written report of Structured Clinical Interviews
for DSM-IV Axis I and Axis II disorders (SCID-I and
SCID-II). If both agree on a formal diagnosis of DID,
the patient is included, baseline assessment is com-
pleted, and the patient is assigned to a participating
therapist.
Ten possible baseline lengths are selected before-
hand (i.e. 11 weeks, up to 20 weeks) and divided in
two pools, one consisting of the five shortest baseline
lengths and the second of the five longest baselines.
When a patient agrees to participate, a baseline length
is randomly selected (without replacement) from a
randomly selected pool. When a second patient is
included at the same site, a baseline length is ran-
domly selected from the pool that was not used
before at the site. At the end of the baseline phase,
an education phase starts with a fixed length of
eight weeks for every patient, encompassing 16 ses-
sions in which an idiosyncratic case-conceptualiza-
tion is made, and the patient is educated on the
schema mode model. After this, the intervention
phase starts. Next, there are 160 sessions twice a
week, after which the frequency is reduced to one
session a week for 40 sessions. After treatment
patients receive six monthly booster sessions. All
patients complete outcome measures on state
6 R. J. C. HUNTJENS ET AL.
dissociative symptoms and PTSD symptoms once a
week in the baseline and education phase, and once
every two weeks in the intervention phase. In addi-
tion, they complete several other outcome measures
(i.e. presence DID, trait dissociative symptoms,
comorbid symptomatology, and global symptomatic
distress) at the start of the baseline phase, start of the
education phase, start of the intervention phase, and
after that every six months until the end of treatment.
After treatment, there is a first follow-up measure-
ment right after the booster sessions (i.e. six months
after treatment), and a second follow-up measure-
ment one year after treatment (see Table 1 for
detailed overview of assessments). No additional
treatment is delivered during the follow-up period,
unless this is deemed clinically necessary (i.e. in case
of acute crisis the emergency procedure of each clin-
ical site is followed). To avoid therapist effects, each
participating therapist only treats one patient.
Participants receive a financial compensation of 150
euros for participation in the assessments.
2.5. Measures
2.5.1. Diagnostic assessments
2.5.1.1. SCID-D-R, SCID-I, and SCID-II. The diag-
nosis DID is verified with the SCID-D-R (Steinberg,
1994, 2004; also see Boon & Draijer, 1993). The
SCID-D-R assesses five symptom clusters (deperso-
nalization, derealization, identity confusion, identity
fragmentation, amnesia) and is considered the gold
standard instrument for the diagnosis of dissociative
disorders. Boon and Draijer (1993) assessed the
Dutch version and reported an excellent interrater
reliability for presence versus absence of a dissocia-
tive disorder and for type of dissociative disorder.
The interview is repeated at the end of treatment,
and at every follow-up.
The Structured Clinical Interviews for DSM-IV Axis I
andAxis II disorders (SCID-I and SCID-II; First, Gibbon,
Spitzer, & Williams, 1997; First, Spitzer, Gibbon, &
Williams, 1996; Lobbestael, Leurgans, & Arntz, 2011;
Van Groenestijn, Akkerhuis, Kupka, Schneider, &
Nolen, 1999; Weertman, Arntz, & Kerkhofs, 2000) with
excellent psychometric properties were used to assess
DSM-IV syndrome disorders and personality pathology.
2.5.2. Baseline assessments
At baseline, patients complete an assessment of
severity of childhood trauma and neglect, and pro-
vide background information (e.g. nationality, mar-
ital status, level of education, terms of employment,
religion).
Severity of childhood trauma and neglect is
assessed with a 28-item brief Childhood Trauma
Questionnaire (CTQ-SF; Bernstein et al., 2003).
Subscales determine emotional abuse, emotional
neglect, sexual abuse, physical abuse, and physical
neglect, each scale consisting of five items plus an
additional three-item minimization/denial scale.
Items are scored on a 5-point Likert scale, reﬂecting
the frequency of maltreatment experiences (range:
never true to very often true). The internal consis-
tency, convergent, and discriminant validity of the
instrument were well supported (Bernstein et al.,
2003; Thombs, Bernstein, Lobbestael, & Arntz, 2009).
Table 1. Assessment per measurement moment.
Measure Method T0 T1 T2 T3
T4–
























thereafter until end of
treatment























SR X X X X X X X X
Short Schema Mode
Inventory (SMI)














SR X X X X X X X X
Int = interview, SR = self-report, T0 = baseline, T1 = baseline-start, T2 =
baseline-end = education-start, T3 = education-end = intervention-
start, T4–T6 = every 40 sessions during intervention, T7 = intervention-
end, T8 = follow-up after six months of booster sessions, T9 = follow-
up one year after end of treatment, six months after end of the booster
sessions.
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2.5.3. Outcome assessments
The primary outcome is the Dissociation Tension
Scale (DTS; Stiglmayr et al., 2010), assessing psycho-
form and somatoform dissociative symptoms in the
past week. The DTS is a 21-item self-report measure
of dissociative symptoms experienced in the past
week. Participants are asked to rate the intensity
using a Likert scale ranging from 0 to 9. The Dutch
version was generated using standard translation and
back-translation procedures. Discrepancies in the
translations were then resolved in dialogue with the
author of the original instrument.
Additional primary outcome measures are the
assessment of diagnosis of DID using the SCID-D-R
(Steinberg, 1994, 2004; also see Boon & Draijer, 1993)
and assessment of patient dropout.
2.5.4. Secondary outcomes
2.5.4.1. PTSD Symptom Scale Self-Report (PSS-
SR). Comorbid PTSD symptoms are assessed with
the PSS-SR (Foa, Riggs, Dancu, & Rothbaum, 1993;
also see Engelhard, Arntz, & van Den Hout, 2007), a
17-item self-report instrument. Because this measure is
taken every two weeks, the instruction was adapted to
refer to symptoms experienced in the past week.
Respondents rate the frequency of each symptom on a
4-point Likert scale ranging from 0 (not at all) to 3 (five
or more times per week/almost always). The English
(Foa et al., 1993) and Dutch versions (Engelhard et al.,
2007) have good psychometric properties.
2.5.4.2. Multidimensional Inventory of Dissociation
(MID). Pathological dissociation is assessed with the
MID (Dell, 2006a, 2006b; Dell & Lawson, 2009). The
MID is a comprehensive 218-item self-report instru-
ment (168 dissociation items, 50 validity items). The
items are rated on a 11-point Likert scale that ranges
from 0 (never) to 10 (always). The scale provides a
summary score between 0 and 100. The MID has
demonstrated adequate reliability and validity (Dell,
2006a; Mueller-Pfeiffer et al., 2013).
2.5.4.3. World Health Organization Disability
Assessment Schedule 2.0 (WHODAS 2.0). To capture
functioning and disability in daily life, the WHODAS
2.0 (36-item version; World Health Organization,
2000) is used. This measure has been recommended
for determination of functional decline secondary to
psychiatric illness by the DSM-5. The WHODAS
examines activity limitations and restrictions for six
different tasks: (1) understanding and communica-
tion; (2) self-care; (3) mobility (getting around); (4)
interpersonal relationships (getting along with
others); (5) work and household roles (life activities);
and (6) community and civic roles (participation).
Items are rated for the extent of difficulty doing the
activity in the past 30 days on a 5-point scale (none,
mild, moderate, severe, extreme/cannot do). The
WHODAS 2.0 has been examined in several different
populations and showed good psychometric proper-
ties (Üstün et al., 2010).
2.5.4.4. Schema Mode Inventory (SMI). Schema
modes are assessed using the SMI (Lobbestael, van
Vreeswijk, Spinhoven, Schouten, & Arntz, 2010).
The SMI consists of 118 items and 14 schema
mode scales (e.g. vulnerable child mode, angry
child mode, detached protector). Items are rated
according to frequency on a 6-point scale from
(almost) never to always. The psychometric results
indicate that the short SMI is a valuable measure
that can be of use for mode assessment in schema
focused therapy (Lobbestael et al., 2010).
2.5.4.5. Dissociative Beliefs about Memory
Questionnaire (DBMQ). Beliefs about memory func-
tioning are indexed using the newly developed 16-item
Dissociative Beliefs about Memory Questionnaire;
Huntjens, & Dorahy, 2018). As recent studies of inter-
identity amnesia in DID suggest that reported memory
problems in DID are not the result of impaired coding
and/or retrieval functioning, but rather may result from
metacognition, this instrument assesses meta-memory
beliefs related to dissociative experiences with 16 items
and four subscales (Fragmentation, Fear of Retrieval of
Negative Events, Amnesia, and Lack of Self-Reference)
using a 1 (not at all/not applicable) to 5 (very much)
scale. Preliminary analyses have indicated good psycho-
metric properties (Huntjens & Dorahy, in preparation).
2.5.4.6. Progress in Treatment Questionnaire
(PITQ). Finally, progress in treatment is determined
using the Progress in Treatment Questionnaire, con-
sisting of a part to be completed by the therapist
(PITQ-t) and a part to be completed by the patient
(PITQ-p) (Schielke, Brand, & Marsic, 2017). This
questionnaire was specifically developed for treat-
ment research in dissociative disorders and assesses
(therapist ratings of) the patients’ ability to safely and
effectively manage their emotions, symptoms, and
relationships. Each item offers 11 response options
ranging from 0% (never) to 100% (always) in 10%
intervals. In the current study, both the PITQ-t is
used and a selection of six items from the PITQ-p
specifically referring to the integration of dissociative
identities. The Dutch version was generated using
standard translation and back-translation procedures.
Discrepancies in the translations were then resolved
by dialogue with the author of the original instru-
ment. Both the PITQ-p and the PITQ-t demonstrated
good internal consistency and evidence of moderate
convergent validity in relation to relevant established
measures (Schielke et al., 2017).
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2.6. Statistical analysis
To assess the difference between the baseline and
intervention phase, a mixed regression approach
will be used, applied successfully in previous com-
parable case series studies (Arntz et al., 2013;
Brewin et al., 2009; Van Den Noortgate &
Onghena, 2003; Videler et al., 2017). To determine
pre- to post-treatment individual change, a Reliable
Change Index (Jacobson & Truax, 1991) will be
calculated for instruments for which appropriate
normative data are available.
3. Discussion
DID is a highly debated disorder with disagreement
on the aetiology (including the relation to child-
hood trauma), the diagnosis, and the treatment of
the disorder. Whereas consensus-based treatment
guidelines are lacking, the practice-based expert
DID guidelines forwarded by the ISSTD (2011)
advocate a phase-based approach to treatment.
However, empirical evidence supporting this
approach is scarce and of low quality. Hence, the
field is in need of methodologically stronger effec-
tiveness studies. Moreover, there is ample room for
improvement in the treatment of these patients,
given the long mean treatment length, the dropout
rates, and relatively large percentage of patients not
moving beyond the phase of establishing safety and
symptom stabilization.
The goal of the current study is to provide a first
test of the effectiveness of a manualized alternative
treatment approach for DID (i.e. schema therapy)
with the use of a methodologically sophisticated
design in the form of a non-concurrent experimen-
tal multiple baseline design. To this end, a treat-
ment protocol was designed, describing the use of
schema therapy in DID. The primary outcome are
dissociative symptoms, presence of DID diagnosis,
and patient dropout. Secondary outcome measures
include measures of posttraumatic symptoms, trait
dissociative symptoms, comorbid symptomatology,
daily functioning, progress in treatment, meta-
memory beliefs, and mode functioning. Strengths
of the treatment approach forwarded include: (1)
it is based on an evidence-based therapy for
patients with a background of severe childhood
trauma in childhood, the latter being considered
by many as the main etiological cause of DID, (2)
there is a broad focus covering a wide array of
consequences following childhood trauma, includ-
ing posttraumatic complaints and personality
pathology, (3) a shorter treatment length, compared
to current ISSTD guidelines, and earlier active
trauma focused treatment ingredients (i.e. com-
pared to a relatively long phase aimed purely at
establishing safety and symptom stabilization), (4)
an emphasis on overcoming cognitive avoidance, a
hallmark characteristic of DID (see Huntjens et al.,
2014), and finally, (5) the approach is in agreement
with recent findings from experimental memory
research on inter-identity amnesia. Acknowledging
the subjective experience of patients, the treatment
approach forwarded in this study considers the
personality states in DID as different emotional,
behavioural, and cognitive states of one underlying
unified identity.
Despite the controlled experimental design, the
relatively small number of patients included limits
the generalizability of the study results. This study
therefore serves as a natural first investigation of the
effectiveness of schema therapy for DID. It should be
replicated in larger samples and other settings.
Furthermore, one might argue that a possible limita-
tion of this study treatment protocol is that DID is
taken as a disorder of self-understanding instead of
involving discrete compartmentalized parts with rela-
tive autonomous functioning. Some clinical experts
consider DID to involve discrete, personiﬁed beha-
vioural states or ‘biopsychosocial action systems’ that
take ‘executive control of the person’s body and
behaviour’ (Van der Hart, Nijenhuis, & Steele,
2006). In the current approach, whereas the patient’s
experience of fragmentation is acknowledged and
validated, we start from the premise of a single per-
son with subjectively divided self-aspects. This agrees
with the guidelines of the ISSTD (2011) where clin-
icians are discouraged from using terms that would
reinforce a belief that alternate identities in DID are
separate persons. Also, experts acknowledge: ‘We do
not disagree that DID is in part a disorder of self-
understanding. Clearly those with DID have the inac-
curate idea that they are more than one person’
(Dalenberg et al., 2012, p. 568). We thus take a
more trans-diagnostic model as a starting point,
emphasizing common pathways comprised of partly
overlapping clinical syndromes such as complex
PTSD, dissociative disorders, and borderline phe-
nomena (see Şar, 2017).
Finally, and most importantly, the results of this
study might help to ameliorate treatment for DID
patients, a group of patients for which, at present, no
evidence-based treatment is available and very much in
need of effective and feasible clinical help. Evidence-
based treatment is a necessary prerequisite for the for-
mulation and acceptance of evidence-based consensus
treatment guidelines for this controversial disorder.
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